Profile | GDS4284 / 1559777_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 111.021 | 38 |
GSM687648 | Patient 402 control | 144.224 | 43 |
GSM687653 | Patient 403 control | 105.074 | 37 |
GSM687658 | Patient 404 control | 265.119 | 53 |
GSM687663 | Patient 411 control | 166.772 | 44 |
GSM687668 | Patient 422 control | 94.5785 | 34 |
GSM687673 | Patient 424 control | 289.855 | 54 |
GSM687678 | Patient 425 control | 247.497 | 51 |
GSM687683 | Patient 427 control | 227.492 | 49 |
GSM687688 | Patient 428 control | 114.106 | 37 |
GSM687695 | Patient 441 control | 741.889 | 70 |
GSM687699 | Patient 443 control | 180.252 | 42 |
GSM687704 | Patient 444 control | 81.5302 | 31 |
GSM687707 | Patient 448 control | 178.712 | 42 |
GSM687712 | Patient 449 control | 152.569 | 42 |
GSM687719 | Patient 450 control | 243.56 | 49 |
GSM687724 | Patient 451 control | 132.923 | 37 |
GSM687728 | Patient 452 control | 541.504 | 65 |
GSM687646 | Patient 401 treated 24h | 86.002 | 32 |
GSM687649 | Patient 402 treated 24h | 165.232 | 46 |
GSM687665 | Patient 411 treated 24h | 211.497 | 47 |
GSM687651 | Patient 402 treated 4 weeks | 158.574 | 42 |
GSM687667 | Patient 411 treated 4 weeks | 150.882 | 42 |
GSM687670 | Patient 422 treated 24h | 171.752 | 44 |
GSM687671 | Patient 422 treated 4 weeks | 136.013 | 41 |
GSM687654 | Patient 403 treated 24h | 101.223 | 37 |
GSM687675 | Patient 424 treated 24h | 270.549 | 52 |
GSM687685 | Patient 427 treated 24h | 169.111 | 45 |
GSM687656 | Patient 403 treated 4 weeks | 46.4742 | 24 |
GSM687677 | Patient 424 treated 4 weeks | 210.972 | 49 |
GSM687687 | Patient 427 treated 4 weeks | 172.813 | 47 |
GSM687692 | Patient 428 treated 4h | 201.666 | 48 |
GSM687716 | Patient 449 treated 4h | 116.693 | 38 |
GSM687722 | Patient 450 treated 4h | 268.268 | 51 |
GSM687680 | Patient 425 treated 24h | 224.242 | 50 |
GSM687690 | Patient 428 treated 24h | 284.094 | 56 |
GSM687700 | Patient 443 treated 24h | 467.143 | 59 |
GSM687705 | Patient 444 treated 24h | 226.054 | 52 |
GSM687714 | Patient 449 treated 24h | 208.111 | 50 |
GSM687721 | Patient 450 treated 24h | 198.3 | 44 |
GSM687682 | Patient 425 treated 4 weeks | 255.522 | 54 |
GSM687694 | Patient 428 treated 4 weeks | 177.465 | 48 |
GSM687702 | Patient 443 treated 4 weeks | 245.496 | 50 |
GSM687718 | Patient 449 treated 4 weeks | 152.763 | 43 |
GSM687723 | Patient 450 treated 4 weeks | 186.86 | 46 |
GSM687661 | Patient 404 treated 4h | 349.129 | 57 |
GSM687710 | Patient 448 treated 4h | 68.5325 | 28 |
GSM687726 | Patient 451 treated 4h | 208.054 | 46 |
GSM687730 | Patient 452 treated 4h | 359.121 | 46 |
GSM687660 | Patient 404 treated 24h | 4231.2 | 92 |
GSM687697 | Patient 441 treated 24h | 794.586 | 71 |
GSM687709 | Patient 448 treated 24h | 119.72 | 36 |
GSM687725 | Patient 451 treated 24h | 244.17 | 49 |
GSM687729 | Patient 452 treated 24h | 1456.79 | 81 |
GSM687727 | Patient 451 treated 4 weeks | 156.247 | 40 |
GSM687731 | Patient 452 treated 4 weeks | 272.025 | 52 |